PAD Paclitaxel Stent Safety Is Again Thrown Into Question - MedPage Today

PAD Paclitaxel Stent Safety Is Again Thrown Into Question  MedPage Today

Key data supporting the safety of paclitaxel-coated devices placed in femoropopliteal lesions has been undermined by serious errors, suggesting the mortality ...



Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management